219 related articles for article (PubMed ID: 17452900)
1. Pitavastatin suppresses acute and chronic rejection in murine cardiac allografts.
Suzuki J; Koga N; Kosuge H; Ogawa M; Haraguchi G; Maejima Y; Saiki H; Isobe M
Transplantation; 2007 Apr; 83(8):1093-7. PubMed ID: 17452900
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone prevents acute and chronic cardiac allograft rejection.
Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
[TBL] [Abstract][Full Text] [Related]
4. Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation.
Ogawa M; Suzuki J; Hishikari K; Takayama K; Tanaka H; Isobe M
J Am Coll Cardiol; 2008 May; 51(20):1977-85. PubMed ID: 18482668
[TBL] [Abstract][Full Text] [Related]
5. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN
Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172
[TBL] [Abstract][Full Text] [Related]
6. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Li J; Xia J; Zhang K; Xu L
J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
[TBL] [Abstract][Full Text] [Related]
7. Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts.
Suzuki J; Ogawa M; Sagesaka YM; Isobe M
Cardiovasc Res; 2006 Jan; 69(1):272-9. PubMed ID: 16109389
[TBL] [Abstract][Full Text] [Related]
8. The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice.
Itoh S; Nakae S; Velotta JB; Kosuge H; Connolly A; Tsai M; Adachi H; Galli SJ; Robbins RC; Fischbein MP
J Heart Lung Transplant; 2010 Apr; 29(4):401-9. PubMed ID: 19818646
[TBL] [Abstract][Full Text] [Related]
9. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts.
Koga N; Suzuki J; Kosuge H; Haraguchi G; Onai Y; Futamatsu H; Maejima Y; Gotoh R; Saiki H; Tsushima F; Azuma M; Isobe M
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2057-62. PubMed ID: 15374847
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of graft arterial disease by manipulation of the LIGHT pathway.
Kosuge H; Suzuki J; Kakuta T; Haraguchi G; Koga N; Futamatsu H; Gotoh R; Inobe M; Isobe M; Uede T
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1409-15. PubMed ID: 15178556
[TBL] [Abstract][Full Text] [Related]
12. Astilbin suppresses acute heart allograft rejection by inhibiting maturation and function of dendritic cells in mice.
Zou S; Shen X; Tang Y; Fu Z; Zheng Q; Wang Q
Transplant Proc; 2010 Nov; 42(9):3798-802. PubMed ID: 21094859
[TBL] [Abstract][Full Text] [Related]
13. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy.
Yamaura K; Ito K; Tsukioka K; Wada Y; Makiuchi A; Sakaguchi M; Akashima T; Fujimori M; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Suzuki J; Amano J; Isobe M
Circulation; 2004 Sep; 110(12):1650-7. PubMed ID: 15364799
[TBL] [Abstract][Full Text] [Related]
14. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
[TBL] [Abstract][Full Text] [Related]
15. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat.
Ekberg H; Qi Z; Pahlman C; Veress B; Bundick RV; Craggs RI; Holness E; Edwards S; Murray CM; Ferguson D; Kerry PJ; Wilson E; Donald DK
Transplantation; 2007 Nov; 84(9):1191-9. PubMed ID: 17998876
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model.
Kimura N; Itoh S; Nakae S; Axtell RC; Velotta JB; Bos EJ; Merk DR; Gong Y; Okamura H; Nagamine CM; Adachi H; Kornfeld H; Robbins RC; Fischbein MP
J Heart Lung Transplant; 2011 Dec; 30(12):1409-17. PubMed ID: 22055099
[TBL] [Abstract][Full Text] [Related]
17. Suppression of (5R)-5-hydroxytriptolide (LLDT-8) on allograft rejection in full MHC-mismatched mouse cardiac transplantation.
Tang W; Zhou R; Yang Y; Li YC; Yang YF; Zuo JP
Transplantation; 2006 Mar; 81(6):927-33. PubMed ID: 16570019
[TBL] [Abstract][Full Text] [Related]
18. [Transfection with virus interleukin-10 to prolong murine heart allograft].
Yang DH; Wu MC; Peng MH; Tzakis A
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):87-91. PubMed ID: 15771810
[TBL] [Abstract][Full Text] [Related]
19. [Expression of non-T cell derived cytokines in acute rejection after heart transplantation: experiment with mouse model].
Liang TB; Yu ZY; Zheng SS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):26-30. PubMed ID: 16606531
[TBL] [Abstract][Full Text] [Related]
20. Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts.
Suzuki J; Morishita R; Amano J; Kaneda Y; Isobe M
Gene Ther; 2000 Nov; 7(21):1847-52. PubMed ID: 11110417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
